Delivery Order SPE2DB24D2216-SPE2DB25FGPAS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,361.04 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Lidocaine 5% Patch 30s. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is expected to be completed by September 8, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30S under a firm fixed-price contract valued at $4,928.37, with an ultimate completion date of October 23, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Lidocaine 5% Patch 30S, a topical pain relief medication. This firm fixed price delivery order, valued at $12.3K, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion and extends through December 2026. The award was made on a competitive, non-set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30S on September 12, 2025, with a ceiling value of $1,414.08 and an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units on July 24, 2025, with a ceiling value of $12,221.66 and a firm fixed price structure. The delivery order represents a competitive award with no set-aside designation and is set for completion by July 25, 2025. This award falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s under a firm fixed-price contract valued at $2,574.15, with completion scheduled for August 13, 2025. This non-competitive delivery order represents a single transaction for a localized pain management pharmaceutical product to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Lidocaine 5% Patch 30-count units, with a ceiling value of $10,834.22 and firm fixed pricing. This competitively awarded, non-set-aside delivery order is scheduled for completion by June 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's substantial...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,551.14 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical. The contract, awarded on June 11, 2025, with an ultimate completion date of June 12, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, serving as the company's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,357.45 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of November 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This competitive award, valued at $1,506.89 with firm fixed pricing, was issued on October 28, 2025, and is scheduled for completion by October 29, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPASDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product, on June 20, 2025. The contract is valued at $1,945.40 with a firm fixed price structure and an ultimate completion date of June 23, 2025. This non-set-aside award represents a competitively awarded delivery order executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical supply vehicle running through December 2026. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is part of AmerisourceBergen's extensive portfolio supporting federal medical procurement needs, particularly for military and veteran healthcare systems. As a major pharmaceutical distributor, the company supplies a comprehensive range of medications and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA Troop Support Medical contract enables the delivery of specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, with AmerisourceBergen operating as one of multiple prime vendors serving distinct regions under the DLA's strategic procurement approach.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 6/20/25 |